Don't forget this important PR last year: http://w
Post# of 30029
""MANF has demonstrated proof of concept in various efficacy and delivery animal models of Parkinson's disease. Going forward, t he Company will look to partner the development of MANF with a group in China capable of bringing this technology to market in that region."